Skip to content
Screener

Krystal Biotech, Inc. KRYS Prepaid & Other Current

Prepaid & Other Current at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$105.78M-17.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$65.65M+9.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$24.74M+60.7%
Regenxbio logo
RegenxbioRGNX
$11.9M+10.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$4.79M+10.2%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$14.82M+18.2%

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$9.66B+143%
Enterprise value$9.17B+152%
P/E42.9×+15.8×
P/S23.2×+12.1×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 7:06 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001711279-26-000043
(in thousands, except par value)March 31,2026December 31,2025
Accounts receivable, net127,022127,425
Inventory42,64640,475
Prepaid taxes10,64214,006
Prepaid expenses and other current assets16,02614,905
Total current assets1,019,7411,024,602
Property and equipment, net153,582150,776
Long-term investments193,485128,066
Right-of-use assets7,0357,239

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Krystal Biotech, Inc.'s prepaid & other current?
Krystal Biotech, Inc. (KRYS) reported prepaid & other current of $16.03M in Q1 2026.
How has Krystal Biotech, Inc.'s prepaid & other current changed year-over-year?
Krystal Biotech, Inc.'s prepaid & other current decreased by 4.3% year-over-year, from $16.75M to $16.03M.
What is the long-term trend for Krystal Biotech, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s prepaid & other current has grown at a 31.5% compound annual growth rate (CAGR), from $3.8M to $14.91M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Krystal Biotech, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude